Literature DB >> 22454866

Dose-response relationships in tropicamide-induced mydriasis and cycloplegia.

S E Smith1.   

Abstract

1 Mydriatic and cycloplegic effects of tropicamide in the normal and in the guanethidine-treated human eye have been recorded following prolonged exposure of the eye to drug solutions. 2 Marked effects and satisfactory dose-response relationships were observed at drug concentrations within the range 1.25-40 μg/ml, by comparison with concentrations of 5-10 mg/ml usually applied as eye-drops. 3 The findings are discussed in relation to drug concentrations which produce cholinergic antagonism in vitro.

Entities:  

Year:  1974        PMID: 22454866      PMCID: PMC1402417          DOI: 10.1111/j.1365-2125.1974.tb00203.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  5 in total

1.  Tropicamide, a new cycloplegic mydriatic.

Authors:  B C GETTES
Journal:  Arch Ophthalmol       Date:  1961-05

2.  Mydriatic drugs for routine fundal inspection. A reappraisal.

Authors:  S E Smith
Journal:  Lancet       Date:  1971-10-16       Impact factor: 79.321

3.  Drug-absorption analysis from pharmacological data. II. Transcorneal biophasic availability of tropicamide.

Authors:  R D Schoenwald; V F Smolen
Journal:  J Pharm Sci       Date:  1971-07       Impact factor: 3.534

4.  Actions of some autonomic drugs on the human eye. Experiments on medical students.

Authors:  M J Mattila; S Takki; J E Idänpään-Heikkilä
Journal:  Ann Med Exp Biol Fenn       Date:  1967

5.  A comparison of the affinities of antagonists for acetylcholine receptors in the ileum, bronchial muscle and iris of the guinea-pig.

Authors:  R B Barlow; F M Franks; J D Pearson
Journal:  Br J Pharmacol       Date:  1972-10       Impact factor: 8.739

  5 in total
  1 in total

1.  The human pupil as a model for clinical pharmacological investigations.

Authors:  P Turner
Journal:  J R Coll Physicians Lond       Date:  1975-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.